Incidence of hemorrhage among anticoagulated patients receiving antiplatelet therapy after percutaneous coronary intervention

Journal of Thrombosis and Thrombolysis

Volumn 29, Issue 3, 2010, Pages 316-321

  Olson, Kari L ^a,b   Delate, Thomas ^a,b   Johnson, Samuel G ^a,b   Wilson, Erika Dawn ^a   Witt, Daniel M ^a,b  

^a Pharmacy Department   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Aspirin therapeutic use; Drug eluting stents; Hemorrhage chemically induced; International normalized ratio; Percutaneous coronary; Warfarin adverse effects; Warfarin therapeutic use

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; WARFARIN; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTERY THROMBOSIS; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; CARDIOMYOPATHY; COHORT ANALYSIS; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY STENT; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG SAFETY; EPISTAXIS; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART ATRIUM FIBRILLATION; HEMATOMA; HEMATURIA; HOSPITAL DISCHARGE; HUMAN; INCIDENCE; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PERCUTANEOUS CORONARY INTERVENTION; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT DURATION; VALVULAR HEART DISEASE; CHEMICALLY INDUCED; COMPARATIVE STUDY; HEMORRHAGE; MIDDLE AGED; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTICOAGULANTS; COHORT STUDIES; FEMALE; HEMORRHAGE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; RETROSPECTIVE STUDIES; ANGIOPLASTY, BALLOON, CORONARY;

EID: 77957944730     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-009-0343-1     Document Type: Article

References (18)

1. Rosamond W, Flegal K, Furie K et al (2008) Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117: e25-e146. doi:10.1161/CIRCULATION AHA.107.187998
2. Antman EM, Hand M, Armstrong PW et al (2008) 2007 Focused Update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 writing group to review new evidence and update the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction, writing on behalf of the 2004 writing committee. Circulation 117:296-329. doi:10.1161/CIRCULATIONAHA.107. 188209
3. King SB III, Smith SC Jr, Hirshfeld JW Jr et al (2008) 2007 Focused Update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 writing group to review new evidence and update the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention, writing on behalf of the 2005 writing committee. Circulation 117:261-295. doi:10.1161/CIRCULATIONAHA.107.188208
4. Anderson JL, Adams CD, Antman EM et al (2007) ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 guidelines for the management of patients with unstable Angina/Non ST-elevation myocardial infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation 116: e148-e304. doi:10.1161/CIRCULATIONAHA. 107.737312
5. Mehta SR, Yusuf S, Peters RJ et al (2001) Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 358:527-533. doi:10.1016/S0140-6736 (01) 05701-4
6. Steinhubl SR, Berger PB, Mann JT III et al (2002) Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 288:2411-2420. doi:10.1001/jama.288.19.2411 (Pubitemid 35340537)
7. Hirsh J, Guyatt G, Albers GW et al (2008) Executive summary: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133:71S-109S. doi: 10.1378/chest.08-0693 (Pubitemid 351892961)
8. Rossini R, Musumeci G, Lettieri C et al (2008) Long-term outcomes in patients undergoing coronary stenting on dual oral antiplatelet treatment requiring oral anticoagulant therapy. Am J Cardiol 102:1618-1623. doi:10.1016/j.amjcard.2008.08.021
9. Sandhoff BG, Nies LK, Olson KL et al (2007) Clinical pharmacy cardiac risk service for managing patients with coronary artery disease in a health maintenance organization. Am J Health Syst Pharm 64:77-84. doi:10.2146/ ajhp060022 (Pubitemid 46395712)
10. Witt DM, Sadler MA, Shanahan RL et al (2005) Effect of a centralized clinical pharmacy anticoagulation service on the outcomes of anticoagulation therapy. Chest 127:1515-1522. doi: 10.1378/chest.127.5.1515 (Pubitemid 46218774)
11. DeEugenio D, Kolman L, DeCaro M et al (2007) Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy. Pharmacotherapy 27:691-696. doi:10.1592/phco.27.5.691 (Pubitemid 46700961)
12. Orford JL, Fasseas P, Melby S et al (2004) Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation. Am Heart J 147:463-467. doi:10.1016/j.ahj.2003.06.004 (Pubitemid 38880866)
13. Mattichak SJ, Reed PS, Gallagher MJ et al (2005) Evaluation of safety of warfarin in combination with antiplatelet therapy for patients treated with coronary stents for acute myocardial infarction. J Interv Cardiol 18:163-166. doi:10.1111/j.1540-8183. 2005.04065.x
14. Khurram Z, Chou E, Minutello R et al (2006) Combination therapy with aspirin, clopidogrel and warfarin following coronary stenting is associated with a significant risk of bleeding. J Invasive Cardiol 18:162-164
15. Porter A, Konstantino Y, Iakobishvili Z et al (2006) Short-term triple therapy with aspirin, warfarin, and a thienopyridine among patients undergoing percutaneous coronary intervention. Catheter Cardiovasc Interv 68:56-61. doi:10.1002/ccd.20733 (Pubitemid 44024462)
16. Karjalainen PP, Porela P, Ylitalo A et al (2007) Safety and efficacy of combined antiplatelet-warfarin therapy after coronary stenting. Eur Heart J 28:726-732. doi:10.1093/eurheartj/ehl488 (Pubitemid 46439228)
17. Sarafoff N, Ndrepepa G, Mehilli J et al (2008) Aspirin and clopidogrel with or without phenprocoumon after drug eluting coronary stent placement in patients on chronic oral anticoagulation. J Intern Med 264:472-480. doi:10.1111/j.1365-2796.2008. 01989.x
18. Ruiz-Nodar JM, Marin F, Hurtado JA et al (2008) Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis. J Am Coll Cardiol 51:818-825. doi:10.1016/j.jacc. 2007.11.035 (Pubitemid 351255616)